ResearcherThomas Jefferson UniversityNo recent work listed

H Zhou

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR. Co-author DOI 10.1038/cddis.2016.169 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fernando F. Blanco · 1 shared paper, 2016 · strength 0.06
- Paper GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help f… DOI 10.1038/cddis.2016.169 ↗
Masaya Jimbo · 1 shared paper, 2016 · strength 0.06
- Paper GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help f… DOI 10.1038/cddis.2016.169 ↗
Isidore Rigoutsos · 1 shared paper, 2016 · strength 0.06
- Paper GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help f… DOI 10.1038/cddis.2016.169 ↗
Jonathan Robert Brody · 1 shared paper, 2016 · strength 0.06
- Paper GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help f… DOI 10.1038/cddis.2016.169 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.